Patents Assigned to Roche Diabetes Care, Inc.
-
Patent number: 11835511Abstract: A resealable container including a housing, a lid coupled to the housing, and a basket received within the housing and including side walls defining an interior space, and a retainer extending over at least a portion of the interior space and configured to support at least one test element in at least one of a side-to-side direction and a front-to-back direction within the basket.Type: GrantFiled: March 9, 2021Date of Patent: December 5, 2023Assignee: ROCHE DIABETES CARE, INC.Inventors: Isaac A. Norman, Frank A. Chan
-
Patent number: 11837078Abstract: An ambulatory medical device for attachment to a person's body includes a housing having a wall and a vibrator coupler. A convex outer surface of the vibrator coupler projects from the wall towards the outside of the housing. The vibrator coupler is coupled to the wall via a connector arranged along the circumference of the vibrator coupler. A vibrator mechanically vibrates upon activation. The vibrator is arranged at least partially inside a volume defined by the vibrator coupler and is mounted to the vibrator coupler. A skin attachment device is also disclosed. It has a substantially planar body having a skin attachment side and an opposing medical device mounting side. The skin attachment side includes a skin attachment structure for releasably attaching the skin attachment device to a person's skin and the medical device mounting side includes a medical device mount for releasably engaging with the ambulatory medical device.Type: GrantFiled: October 1, 2021Date of Patent: December 5, 2023Assignee: Roche Diabetes Care, Inc.Inventors: Steffan Wuerzburger, Hans List
-
Patent number: 11835515Abstract: A method of evaluating suitability of lighting conditions for detecting an analyte in a sample using a mobile device camera. A test strip is provided for detecting the analyte. A first image of the test strip is captured while an illumination source of the mobile device is turned off and a second image of the test strip is captured while the illumination source is turned on. A sample is applied to the test strip and the first and second images are compared to thereby determine the difference in lighting conditions between the first image and the second image. The comparison is used to derive information on suitability of the lighting conditions for analyte detection. The lighting conditions are indicated as suitable when a predetermined threshold amount of light intensity used for illumination of the test strip originates from the illumination source.Type: GrantFiled: December 10, 2020Date of Patent: December 5, 2023Assignee: Roche Diabetes Care, Inc.Inventors: Max Berg, Fredrik Hailer, Timo Klein, Bernd Limburg, Christian Melchinger, Volker Tuerck
-
Publication number: 20230384255Abstract: The present invention relates to a method for the preparation of a working electrode, the method comprising application of a sensing material in several steps. Further, the present invention relates to an analyte sensor comprising the working electrode as well as to the use of the analyte sensor for detecting at least one analyte in a sample.Type: ApplicationFiled: November 22, 2021Publication date: November 30, 2023Applicant: Roche Diabetes Care, Inc.Inventors: Arnfried Guenther, Alexander Steck
-
Publication number: 20230380733Abstract: A medical device for detecting at least one analyte in a body fluid is disclosed.Type: ApplicationFiled: August 2, 2023Publication date: November 30, 2023Applicant: Roche Diabetes Care, Inc.Inventor: Helmut Walter
-
Publication number: 20230371859Abstract: A medical device for detecting at least one analyte in a body fluid, a method for assembling the medical device and a method of using the medical device are disclosed. The medical device comprises: an analyte sensor having an insertable portion; an insertion cannula receiving the insertable portion of the analyte sensor; an electronics unit connected with the analyte sensor; and a housing comprising an electronics compartment receiving the electronics unit and—a sensor compartment receiving the analyte sensor, the sensor compartment forming a sealed compartment receiving the insertable portion of the analyte sensor, the sealed compartment comprising detachable upper and lower caps, the lower cap configured for detachment before insertion, the insertion cannula being attached to the upper cap, wherein detaching the upper cap after insertion removes the insertion cannula, wherein the electronics compartment at least partially surrounds the sensor compartment.Type: ApplicationFiled: July 31, 2023Publication date: November 23, 2023Applicant: Roche Diabetes Care, Inc.Inventor: Helmut Walter
-
Publication number: 20230371856Abstract: A medical device for detecting at least one analyte in a body fluid is disclosed.Type: ApplicationFiled: August 1, 2023Publication date: November 23, 2023Applicant: Roche Diabetes Care, Inc.Inventor: Helmut Walter
-
Publication number: 20230371861Abstract: A medical device for detecting at least one analyte in a body fluid, a method for assembling the medical device and a method of using the medical device are disclosed. The medical device comprises: an analyte sensor having an insertable portion; an insertion cannula receiving the insertable portion of the analyte sensor; an electronics unit connected with the analyte sensor; and a housing comprising an electronics compartment receiving the electronics unit and a sensor compartment receiving the analyte sensor, the sensor compartment forming a sealed compartment receiving the insertable portion of the analyte sensor, the sealed compartment comprising detachable upper and lower caps, the lower cap configured for detachment before insertion, the insertion cannula being attached to the upper cap, wherein detaching the upper cap after insertion removes the insertion cannula, wherein the electronics compartment at least partially surrounds the sensor compartment.Type: ApplicationFiled: August 1, 2023Publication date: November 23, 2023Applicant: Roche Diabetes Care, Inc.Inventor: Helmut Walter
-
Publication number: 20230371857Abstract: A medical device for detecting at least one analyte in a body fluid is disclosed.Type: ApplicationFiled: August 2, 2023Publication date: November 23, 2023Applicant: Roche Diabetes Care, Inc.Inventor: Helmut Walter
-
Publication number: 20230371860Abstract: A medical device for detecting at least one analyte in a body fluid, a method for assembling the medical device and a method of using the medical device are disclosed. The medical device comprises: an analyte sensor having an insertable portion; an insertion cannula receiving the insertable portion of the analyte sensor; an electronics unit connected with the analyte sensor; and a housing comprising an electronics compartment receiving the electronics unit and-a sensor compartment receiving the analyte sensor, the sensor compartment forming a sealed compartment receiving the insertable portion of the analyte sensor, the sealed compartment comprising detachable upper and lower caps, the lower cap configured for detachment before insertion, the insertion cannula being attached to the upper cap, wherein detaching the upper cap after insertion removes the insertion cannula, wherein the electronics compartment at least partially surrounds the sensor compartment.Type: ApplicationFiled: July 31, 2023Publication date: November 23, 2023Applicant: Roche Diabetes Care, Inc.Inventor: Helmut Walter
-
Publication number: 20230364331Abstract: An insertion system comprises a medical device and an insertion device for inserting the medical device into a body tissue of a user, the insertion device comprising: an insertion component-configured for inserting the medical device into the body tissue; an insertion component retractor; a cap; a guide sleeve and an insertion sleeve guided therein; a locking sleeve in the insertion sleeve; and an elastic member positioned between the locking sleeve and the insertion component retractor; wherein, for inserting the medical device, the cap, the insertion component retractor, the locking sleeve and the insertion sleeve are movable relative to the guide sleeve from a distal position to a proximal position, wherein the insertion device is separable from the medical device, wherein the insertion system is separation of the insertion device from the medical device releasing a movement of the locking sleeve from its proximal position to a further proximal position.Type: ApplicationFiled: July 26, 2023Publication date: November 16, 2023Applicant: Roche Diabetes Care, Inc.Inventors: Hans List, Bruno Thoes
-
Publication number: 20230355875Abstract: Medical device efficiency detection methods and systems including a photoplethysmography (PPG) sensor device, a processor, a memory, and machine readable instructions that may cause the system to receive a notification at the PPG device from the medical device upon delivery of the therapy treatment, use the PPG device to search for a signal response of the user based on the notification within a period of time to generate a response signal indicative of therapy treatment delivery, and transmit an alert when the response signal is not generated in the period of time indicative of a failure to detect sufficient therapy treatment delivery. The instructions may cause the system to transmit an alert when signal measurements from the PPG device of an infusion site are not within a sufficient signal range to indicate the infusion site is insufficient for delivery of the therapy treatment by the medical device.Type: ApplicationFiled: July 18, 2023Publication date: November 9, 2023Applicant: Roche Diabetes Care, Inc.Inventors: Timothy N Aykroyd, Alexander Licht, Stephanie Ann Wooten
-
Publication number: 20230351867Abstract: An alert is used to inform a user that their blood glucose level has dropped below a threshold (e.g., the user is hypoglycemic) or has increased above a threshold (e.g., the user is hyperglycemic). There is a hierarchy of alerts from lowest priority to highest priority. The alert is communicated by a user device (e.g., a mobile device), which is, for example, a smartphone, smart watch, home automation device, or the like. The alert is modified in order to increase the likelihood that the user receives or acknowledges the alert within a minimal amount of time. An intensity level (e.g., a volume) of an alert is modified based on, for example, whether the user has acknowledged a previous alert. A modality or a sensory channel of an alert is changed if an initial alert does fails to elicit a response from the user.Type: ApplicationFiled: July 11, 2023Publication date: November 2, 2023Applicant: Roche Diabetes Care, Inc.Inventor: Mark Gilmore Mears
-
Patent number: 11793934Abstract: Disclosed is a medical system having a cartridge and an inserter. The cartridge includes a housing having an interior volume with a first guide within the interior volume. A cradle is disposed within the interior volume and is configured for mounting a medical appliance. The cradle includes a subcutaneous element and an insertion needle. The insertion needle is configured for being actuated to insert the subcutaneous element into a subject. The inserter includes a second guide configured to mate with the housing of the cartridge, and the first guide and second guide are configured to cooperate to guide the inserter into the interior volume along a guiding path defined by the first guide. The inserter is configured to removably attach to the cradle when guided into the interior volume. An insertion assembly is provided for actuating the insertion needle to insert the subcutaneous element into the subject.Type: GrantFiled: June 30, 2020Date of Patent: October 24, 2023Assignee: Roche Diabetes Care, Inc.Inventor: Frank Deck
-
Patent number: 11781973Abstract: A calibration method for calibrating a camera for detecting an analyte in a sample is disclosed. A plurality of different color coordinate systems and a set of test samples are provided. The test samples are applied to test elements that have test fields for producing an optically detectable reaction. Images of the colored test fields are acquired using the camera and color coordinates for the images are generated. The color coordinates that are generated are transformed into a set of measured concentrations by using a set of coding functions. The set of measured concentrations is compared with the known concentrations of the test samples and a best match color coordinate system of the plurality of color coordinate systems is determined. A best match coding function of the plurality of coding functions is also determined.Type: GrantFiled: August 24, 2020Date of Patent: October 10, 2023Assignee: Roche Diabetes Care, Inc.Inventors: Bernd Limburg, Max Berg, Fredrik Hailer
-
Publication number: 20230317243Abstract: Systems and methods are provided for improving nutritional element content estimates from one or more individuals and/or determining a therapy or treatment based on a nutritional element content estimate and improving diabetes management. The systems and methods include a therapy or treatment display based on at least one nutritional element content estimate and at least one proficiency index respectively assigned to an individual to improve accuracy and reliability when estimating nutritional element content in foods and/or therapy or treatment based therefrom.Type: ApplicationFiled: June 8, 2023Publication date: October 5, 2023Applicant: Roche Diabetes Care, Inc.Inventors: Siva Chittajallu, Rene Valverde-Ventura
-
Patent number: 11771827Abstract: This disclosure concerns a medical device designed for delivering a medical fluid or designed for controlling delivery of a medical fluid, and to a method of operating such a medical device. The medical device comprises a user interface associated with an electronic circuit connected to a first port and to a second port of a controller. The electronic circuit enables the controller to detect actuation of the user interface. The controller is configured to execute the following sequence of steps: first step: configure the first port as an output port and to apply a first signal to the first port; second step: to acquire a second signal from the second port; and third step: to determine on the basis of the second signal if a short circuit has occurred and to generate a short circuit alert signal if applicable.Type: GrantFiled: February 17, 2020Date of Patent: October 3, 2023Assignee: Roche Diabetes Care, Inc.Inventor: Kurt Friedli
-
Publication number: 20230301560Abstract: A user device (e.g., a mobile device) receives testing period data during a testing period. The user device determines that a portion of the data is missing based on an analysis of the received testing period data. The analysis of the received data includes an analysis of one or more blood glucose levels and an analysis of the dietary intake data, the medication data, and the activity data. The user device imputes the missing portion of the data with substitute data determined using predictive learning. The user device calculates a confidence level associated with the substitute data. The user device identifies, using the substitute data, a progression or a regression in a diabetic condition associated with the user.Type: ApplicationFiled: May 30, 2023Publication date: September 28, 2023Applicant: Roche Diabetes Care, Inc.Inventors: Samer M. Dajani, Igor Gejdos, Chinmay Manohar, Joao Rodrigues
-
Patent number: 11759132Abstract: A medical device for detecting, at least one analyte, in a body fluid is disclosed.Type: GrantFiled: February 3, 2017Date of Patent: September 19, 2023Assignee: ROCHE DIABETES CARE, INC.Inventor: Helmut Walter
-
Patent number: 11761947Abstract: According to some embodiments of the present disclosure, a device and method for determining an allowable amount of blood glucose (bG) of a patient is disclosed. The method further includes receiving a current bG measurement, determining a target bG value, and determining a correction delta bG value based on one or more advice history records. The method includes determining a correction meal rise value and determining a maximum allowed bG value based on the target bG value, the correction delta bG value, and the correction meal rise value. The method includes setting the allowable amount of bG value equal to the maximum allowed bG value when the current bG measurement is greater than the target bG value and determining the allowable amount of bG value using the target bG value and the correction delta bG value when the current bG measurement is less than the target bG value.Type: GrantFiled: October 22, 2019Date of Patent: September 19, 2023Assignee: Roche Diabetes Care, Inc.Inventors: Paul Galley, Alan Greenburg, Marshall M. Parker, John F. Price, Robin S. Wagner, Richard W. Wilson